Characterization of a Novel Analogue of 1α,25(OH)2-Vitamin D3 with Two Side Chains: Interaction with Its Nuclear Receptor and Cellular Actions-Reference-Cited by-同舟云学术

Characterization of a Novel Analogue of 1α,25(OH)2-Vitamin D3 with Two Side Chains: Interaction with Its Nuclear Receptor and Cellular Actions

Published:2000-06-21 Issue:14 Volume:43 Page:2719-2730
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Norman Anthony W.¹,Manchand Percy S.¹,Uskokovic Milan R.¹,Okamura William H.¹,Takeuchi Janet A.¹,Bishop June E.¹,Hisatake Jun-Iichi¹,Koeffler H. Phillip¹,Peleg Sara¹

Affiliation:

1. Departments of Biochemistry and Chemistry and Division of Biomedical Sciences, University of California, Riverside, California 92521, Hoffmann-La Roche Inc., Nutley, New Jersey 07110, Division of Hematology/Oncology, Cedars−Sinai Medical Center, UCLA School of Medicine, 8700 Beverly Boulevard, B-208, Los Angeles, California 90048, and Department of Medical Specialties, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0000160

Reference46 articles.

1. The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed

2. The Role of the Vitamin D Endocrine System in Health and Disease

3. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Biological Evaluation of New Type of Gemini Analogues with a Cyclopropane Moiety in Their Side Chain;Journal of Medicinal Chemistry;2024-06-10

2. Structure function relationships of VDR ligands;Feldman and Pike' s Vitamin D;2024

3. Structural basis for ligand activity in vitamin D receptor;Feldman and Pike' s Vitamin D;2024

4. The Centennial Collection of VDR Ligands: Metabolites, Analogs, Hybrids and Non-Secosteroidal Ligands;Nutrients;2022-11-21

5. Strategies for the Design of Vitamin D Receptor Ligands;Nuclear Receptors;2021